HIGHLIGHTS
- who: Lan Wang and collaborators from the State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis, College of Life Science, Henan Normal University, Xinxiang, Henan, China have published the paper: Inhibition of MAD2L1 Mediates Pulmonary Fibrosis through Impairment of Mitochondrial Function and Induction of Cell Senescence, in the Journal: Canadian Respiratory Journal of 28/05/2022
- what: The authors aimed to uncover the role of MAD2L1 in pulmonary fibrosis to find a novel therapeutic target for IPF treatment. The study was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.